Ninety One UK Ltd Makes New $18.61 Million Investment in Humana Inc. $HUM

Ninety One UK Ltd purchased a new position in Humana Inc. (NYSE:HUM) in the third quarter, HoldingsChannel reports. The institutional investor purchased 71,543 shares of the insurance provider’s stock, valued at approximately $18,613,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Elevation Point Wealth Partners LLC purchased a new stake in Humana in the 2nd quarter worth approximately $32,000. Mather Group LLC. acquired a new position in shares of Humana during the 3rd quarter valued at about $34,000. Private Wealth Management Group LLC grew its position in Humana by 47.5% in the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after acquiring an additional 48 shares during the period. AlphaCore Capital LLC purchased a new stake in Humana in the 2nd quarter valued at about $39,000. Finally, CVA Family Office LLC lifted its stake in Humana by 63.4% during the second quarter. CVA Family Office LLC now owns 219 shares of the insurance provider’s stock worth $54,000 after purchasing an additional 85 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on HUM. Truist Financial lowered their price objective on Humana from $300.00 to $285.00 and set a “hold” rating for the company in a research report on Monday, November 10th. Weiss Ratings reissued a “sell (d+)” rating on shares of Humana in a research report on Wednesday, October 8th. Bank of America increased their price target on Humana from $280.00 to $300.00 and gave the stock a “neutral” rating in a report on Friday, October 10th. Robert W. Baird cut their price target on shares of Humana from $280.00 to $264.00 and set a “neutral” rating for the company in a report on Thursday, December 11th. Finally, Sanford C. Bernstein increased their price target on shares of Humana from $269.00 to $341.00 and gave the company an “outperform” rating in a research report on Friday, September 5th. Nine investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $294.32.

Humana Trading Down 1.0%

Shares of HUM opened at $256.35 on Friday. Humana Inc. has a one year low of $206.87 and a one year high of $315.35. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 2.02. The company has a market capitalization of $30.83 billion, a P/E ratio of 24.03, a P/E/G ratio of 1.50 and a beta of 0.45. The stock has a 50-day moving average price of $256.02 and a 200 day moving average price of $260.84.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. Humana had a net margin of 1.02% and a return on equity of 12.86%. The firm had revenue of $32.65 billion during the quarter, compared to the consensus estimate of $31.99 billion. During the same quarter in the previous year, the company posted $4.16 earnings per share. The firm’s revenue was up 11.1% on a year-over-year basis. Sell-side analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date is Friday, December 26th. Humana’s payout ratio is 33.18%.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.